The GBA Multimodal Study in Parkinson's Disease
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- Pacific Parkinson's Research Centre
- Study ID
- NCT04101968
- Status
- Recruiting
Conditions
- GBA Gene Mutation
- Gaucher Disease
- Parkinson Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- PET scan — DIAGNOSTIC_TEST3 PET scans to analyze the dopamine metabolism, acetylcholine and tau protein deposition in the brain.
- neuroQWERTY — DIAGNOSTIC_TESTAnalysis of free-text typing in a computer and/or a touch-screen device.
Study Details
This study plans to analyze the molecular and clinical mechanisms of the relationship between the GBA mutations and Parkinson's disease. This will be assessed through the use of advanced neuroimaging techniques called PET (positron emission tomography) to study the accumulation of the tau protein and the dysfunction of acetylcholine and dopamine in the brain of people with a mutation in the GBA gene, with and without Parkinson's disease. The ingestigators will also use a technology-based assessment to study the typing patterns as possible biomarkers of early motor dysfunctions.
Key Dates
- Start date
- May 1, 2019
- Status verified
- May 2025
- Primary completion
- Dec 30, 2025
- Completion
- Dec 30, 2025
Study Design
- Enrollment
- 25 participants (estimated)
Arms
- Arm: GBA-PDPeople with Parkinson's disease who are known heterozygous carriers of pathogenic GBA gene mutations.
- Arm: Asymptomatic GBAKnown heterozygous carriers/obligated carriers of pathogenic GBA gene mutations.
Primary Outcome Measure
Acetylcholinesterase activity [ Time Frame: baseline ]
Central Contacts
- Jessamyn McKenzie6048227764
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Oregon Health & Science University | Portland | Oregon | 97239 | Matthew Brodsky, MD (PRINCIPAL_INVESTIGATOR) |
| University of Washington | Seattle | Washington | 98108-1595 | Cyrus P Zabetian, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Portland, OR
By condition
By specialty
Related Studies
- International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registryRecruiting · Genzyme, a Sanofi Company · Phoenix, Arizona
- North American Prodromal Synucleinopathy ConsortiumEnrolling By Invitation · Washington University School of Medicine · Sun City, Arizona
- Deep Brain Stimulation (DBS) Retrospective Outcomes StudyRecruiting · Boston Scientific Corporation · Phoenix, Arizona
- Study in Parkinson Disease of ExerciseRecruiting · Northwestern University · Birmingham, Alabama